Posts Tagged ‘Safety Intelligence Program’

SIP Version 3.0.4 update

Friday, April 16th, 2010

BioWisdom have released a Safety Intelligence Program update, with some new functionality and data. Since the September 2009 Version 3.0 release, there has been significant increase in the data sources accessed through SIP. Of particular interest are the following:

  • ChEMBL: This is a database of bioactive drug-like small molecule, which contains 2-D structures, calculated properties and abstracted bioactivities (e.g. binding constants, pharmacology and ADMET data). BioWisdom have mapped data from some of the bioassays to key concepts such as Cytotoxicity, Cell growth, Cell proliferation, Neoplasia, and also from the binding assays for compound – protein assertions.
  • National Toxicology Program: There are now assertions from several sets of data from National Toxicology Program, including chemicals associated with site-specific tumor induction in liver; some data from the NTP Study Reports; and some Bioassay  Pathology data.
  • Medline: We have increased the coverage of the uncurated assertions (at 75% accuracy), to cover physiological processes (e.g. cell proliferation, apoptosis, protein biosynthesis) as well as the original Broad Sweep pathological observation data. This enhances the use of SIP for mechanistic understanding of potential liabilities of compounds.

Email us at sip@biowisdom.com if you want to find out more about SIP.

About the Safety Intelligence Program

Wednesday, February 17th, 2010

Safety Intelligence ProgramA collaborative program for safety intelligence

The Safety Intelligence Program is an industry-sponsored initiative that embraces the expertise of its pharmaceutical members and other stakeholders to build the world’s most comprehensive intelligence resource for use in improving drug safety assessments. Joining the program brings a wealth of benefits, including access to the Safety Intelligence System and participation in an interactive community under the Safety Intelligence Program Members Forum.Bio-IT Best Practices Award 2009

An unparalleled resource for drug safety

The Safety Intelligence System represents the largest forever-expanding collection of known effects of chemicals occurring in the different tissue, drugs effects on clinical biomarkers of tissue injury and drug molecular mechanisms.

The System currently contains almost 100,000 individual ‘facts’ assertions relating to the liver responses, affected by over 5,500 different compounds in over 20 different species. These assertions distill the observations and conclusions made across more than 19 million documents and database records, including regulatory documents, drug labels, pre-clinical and clinical research journals.

Using our intelligent search technology, we automatically ‘read’ millions of documents and store key observations as ‘assertional meta-data’. This meta-data is stored in a semantically consistent format which dramatically improves the pace and efficiency of analysis. Although millions of documents are read automatically, a task which would take hundreds of highly trained experts many months to achieve, we are able with rigorous quality control by PhD level scientists to deliver over 97% accuracy.

Members Forum: A Global community

The Members Forum gives you the opportunity to interact with a rapidly expanding community of scientists (clinical or preclinical; chemist or biologists) all with a common interest in using the Safety Intelligence System to improve our understanding of mechanisms of drug-related adverse events. All Members have access to a series of large scale assertional meta-data analyses performed by us or other members and the opportunity to participate in a series of Webinars or other forms of interaction with other scientists. This creates the opportunity to learn from others about their applications of the Safety Intelligence System and the ever growing collection of assertional meta-data.

An intuitive search interface

The Safety Intelligence System is accessible using an internet explorer from anywhere in the world.Screenshot of the Safety Intelligence Program interface

As well as the usual ‘quick search’ box for keyword searching, the system allows searching by chemical structure. Advanced ‘assertional meta-data’ searching is also possible, for example, you can search for all compounds causing liver necrosis in seconds. Our unique format of ‘assertional meta-data’ allows you to complex analyses to be performed.

Any search can be saved as a favourite to speed up future searching and the system has in-built alerting functionality so you will be automatically notified of any changes in the data that impact a saved query.

Coming soon….

The content of the Safety Intelligence System is expanding daily. In the next three months, we will expand the assertional meta-data in the System to other tissues, starting with the cardiac system, followed by kidney. The list of data sources used is also expanding, we are currently working on the FDA New Drug Applications for liver effects – this will also be available in the next 3 months. The content grows according to the sponsorship of our Charter Members. As a Charter Member, you prioritise what is created built and when; in return Charter Members receive perpetual rights to the data.

The Safety Intelligence Program – How to get involved

Wednesday, February 17th, 2010

Access SIP

If you are already a member, you can access SIP here.

Free Trial

For a free trial of SIP, please email us at sip@biowisdom.com.

Join Now

Download the membership options leaflet.

Alternatively, email sip@biowisdom.com for more information or if you would prefer to contact us directly, please call our telephone sales department, United Kingdom +44 (0)1223 874838. Our telephone sales are open during normal office hours 09:00 to 17:30, Monday through Friday.

Demonstrations

You can access all SIP demonstrations and tutorials here or you can download the videos below.

Webinars

You can access all SIP webinars here.

More Information

Intelligence for Drug Safety

Thursday, December 10th, 2009

Safety Intelligence Program
The Assertional Metadata (AMD) contained within our Safety Intelligence Program (SIP) represents the largest ever-expanding collection of known effects of chemicals occurring in the different tissue, drugs effects on clinical biomarkers of tissue injury and drug molecular mechanisms.

Read more about Intelligence for Drug Safety »